A mum was diagnosed with breast cancer after attending a routine screening … , ER-negative breast cancer - a common type of breast cancer where cancer cells … continue to receive the drug Herceptin every three weeks. In April …

… line HER2-positive metastatic breast cancer treatment, revealed that … of taxane, trastuzumab (Herceptin), and pertuzumab. The … positive metastatic triple-negative breast cancer. These findings come … treatment lines of metastatic breast cancer. Catch the full …

… subsidiary CuraTeQ Biologics’ biosimilar for breast cancer has been recommended for marketing … HER2-positive metastatic and early breast cancers,” Aurobindo Pharma said on … and the reference biologic product Herceptin in terms of pharmacokinetics, …

… mum was diagnosed with breast cancer despite having no symptoms during … two positive, ER-negative breast cancer. She says the devastating … to receive the drug Herceptin every three weeks, but … these new drugs, trastuzumab (Herceptin), targets HER2 and is now …

… HER2-positive metastatic and early breast cancers. Trastuzumab specifically binds and inhibits … and the reference biologic product Herceptin in terms of pharmacokinetics (PK …

… (HR)–positive, HER2-positive metastatic breast cancer. Data from the phase 3 … HR-positive, HER2-positive metastatic breast cancer, Desai began. Following these findings … either receive palbociclib plus trastuzumab (Herceptin) or pertuzumab (Perjeta) and ET …

… on anti-cancer drug Herceptin to help slow the … support the work of Breast Cancer Foundation NZ, with people … pregnancy, according to the Breast Cancer Foundation website. “Most women … annual fundraising campaign for Breast Cancer Foundation NZ, with proceeds …

… receptor–positive, HER2-positive metastatic breast cancer. According to results from the … Antonio Breast Cancer Symposium, the addition of palbociclib to SOC trastuzumab (Herceptin) with …

… Medical Director, Evelyn H. Lauder Breast Cancer Center and the Norna S … Founding Scientific Director of the Breast Cancer Research Foundation, Past President of … development of major pharmaceuticals, including Herceptin and Enhertu, which he shepherded …

… pathways in cancer progression:  - Breast Cancer: EGCG binds to HER2 receptors … effects of chemotherapy drugs like Herceptin. - Prostate Cancer: Inhibits 5 …